Reading and Resources

Aggarwal R, Ringold S, Khanna D, et al. Distinctions between diagnostic and classification criteria? Arthritis Care Res (Hoboken). 2015;67:891-897.

Braun J. Axial spondyloarthritis including ankylosing spondylitis. Rheumatology (Oxford). 2018;57(suppl 6):vi1-vi3.

Cheung PP. Anti-IL17A in axial spondyloarthritis—where are we at? Front Med (Lausanne). 2017;4:1.

Danve A, Deodhar A. Axial spondyloarthritis in the USA: diagnostic challenges and missed opportunities. J Clin Rheumatol. 2019;38:625-634.

Dubash S, McGonagle D, Marzo-Ortega H. New advances in the understanding and treatment of axial spondyloarthritis: from chance to choice. Ther Adv Chronic Dis. 2018;9:77-87.

Dubreuil M, Deodhar AA. Axial spondyloarthritis classification criteria: the debate continues. Curr Opin Rheumatol. 2017;29:317-322.

Magrey M, Ritchlin C. Measuring outcomes in ankylosing spondylitis: pearls and pitfalls. Curr Opin Rheumatol. 2019;31:109-117.

Marzo-Ortega H, Gaffney KM, Gaffney K. Defining the target: clinical aims in axial spondyloarthritis. Rheumatology (Oxford). 2018;57(suppl 6):vi18-vi22.

Noureldin B, Barkham N. The current standard of care and the unmet needs for axial spondyloarthritis. Rheumatology (Oxford). 2018;57(suppl 6):vi10-vi17.

Paine A, Ritchlin CT. Targeting the interleukin-23/17 axis in axial spondyloarthritis. Curr Opin Rheumatol. 2016;28:359-367.

Proft F, Poddubnyy D. Ankylosing spondylitis and axial spondyloarthritis: recent insights and impact of new classification criteria. Ther Adv Musculoskelet Dis. 2018;10:129-139.

Rudwaleit M, van der Heijde D, Landewé R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68:777-783.

Sieper J, Poddubnyy D. Axial spondyloarthritis. Lancet. 2017;390:73-84.

Strand V, Singh JA. Patient burden of axial spondyloarthritis. J Clin Rheumatol. 2017;23:383-391.

Terenzi R, Monti S, Tesei G, Carli L. One year in review 2017: spondyloarthritis. Clin Exp Rheumatol. 2018;36:1-14.

Torgutalp M, Poddubnyy D. IL-17 inhibition in axial spondyloarthritis: current and future perspectives. Expert Opin Biol Ther. 2019;19:631-641.

van der Heijde D, Ramiro S, Landewé R, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017;76:978-991.

Wang R, Ward MM. Epidemiology of axial spondyloarthritis: an update. Curr Opin Rheumatol. 2018;30:137-143.

Ward MM, Deodhar A, Akl EA, et al. American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheumatol. 2016;68:282-298.

 

Patient Education

CreakyJoints. Raising the Voice of Patients: A Patient’s Guide to Living with Ankylosing Spondylitis. https://creakyjoints.org/education/ankylosing-spondylitis-patient-guidelines

Spondylitis Association of America. www.spondylitis.org/Educational-Materials-Resources

Yu D, van Tubergen A. Patient education: Axial spondyloarthritis, including ankylosing spondylitis (Beyond the Basics). www.uptodate.com/contents/axial-spondyloarthritis-including-ankylosing-spondylitis-beyond-the-basics

 

Clinical Trials

NIH US National Library of Medicine. ClinicalTrials.gov. www.clinicaltrials.gov

 

Professional Organizations

American College of Rheumatology. www.rheumatology.org

CreakyJoints. https://creakyjoints.org

National Institute of Arthritis and Musculoskeletal and Skin Diseases. www.niams.nih.gov

National Library of Medicine. www.nlm.nih.gov/medlineplus/healthtopics.html

Spondylitis Association of America. www.spondylitis.org

Spondyloarthritis Research and Treatment Network. www.spartangroup.org

The Arthritis Foundation. www.arthritis.org

Scroll to Top